Next-Generation Sequencing of Carbapenem-Resistant Strains Isolated from Patients Hospitalized in the University Hospital Facilities.

Ján Koreň, Michal Andrezál, Hana Drahovská, Zuzana Hubenáková, Adriána Liptáková, Tibor Maliar
Author Information
  1. Ján Koreň: Institute of Microbiology, Faculty of Medicine, Comenius University, University Hospital Bratislava, 81108 Bratislava, Slovakia.
  2. Michal Andrezál: Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia.
  3. Hana Drahovská: Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia.
  4. Zuzana Hubenáková: Institute of Microbiology, Faculty of Medicine, Comenius University, University Hospital Bratislava, 81108 Bratislava, Slovakia.
  5. Adriána Liptáková: Institute of Microbiology, Faculty of Medicine, Comenius University, University Hospital Bratislava, 81108 Bratislava, Slovakia. ORCID
  6. Tibor Maliar: Department of Biotechnologies, Faculty of Natural Sciences, University of SS. Cyril and Methodius in Trnava, 91701 Trnava, Slovakia.

Abstract

carbapenem-resistant (CR) represents an urgent worldwide threat. We focused on CR in selected facilities of the University Hospital Bratislava (UHB) to investigate sequence types (STs), clonal relatedness, and antimicrobial resistance. Suspected carbapenem-nonsusceptible strains were obtained from hospitalized patients. Further examination included carbapenemase confirmation, cgMLST, and quantitative susceptibility testing. Of the total 41 CR strains, 26 (63.4%) were determined as ST11 in hospital No. 1; of these ST11, 22 (84.6%) were found in the first internal clinic. Six (14.6%) ST258 and three (7.3%) ST584 occurred in hospital No. 2; the most, i.e., four (66.7%), ST258 were detected in the geriatric clinic. In hospital No. 3, we found two (4.8%) ST584 and one (2.4%) ST258. Of the ST11 set, 24 (92.3%) produced NDM-1. Furthermore, seven (87.5) ST258 and five (100%) ST584 strains generated KPC-2. Antimicrobial resistance was as follows: ertapenem 97.6%, meropenem 63.4%, tigecycline 7.3%, eravacycline 7.3%, and colistin 2.5%. We revealed a presumably epidemiological association of ST11 with transmission, particularly in the first internal clinic of hospital No. 1, while ST258 and ST584 were related to interhospital dissemination between medical facilities No. 2 and No. 3. It is essential to prevent the circulation of these pathogens within and between healthcare facilities.

Keywords

References

  1. Clin Infect Dis. 2019 Mar 5;68(6):964-971 [PMID: 29986007]
  2. Lancet Infect Dis. 2022 Jan;22(1):e28-e34 [PMID: 34246322]
  3. J Hosp Infect. 2018 Sep;100(1):1-8 [PMID: 30173875]
  4. Front Microbiol. 2020 Jul 15;11:1563 [PMID: 32760368]
  5. Clin Infect Dis. 2018 Mar 19;66(7):1061-1067 [PMID: 29099915]
  6. Front Microbiol. 2019 Jan 30;10:80 [PMID: 30761114]
  7. Molecules. 2020 Mar 20;25(6): [PMID: 32245012]
  8. J Clin Med. 2019 Jun 28;8(7): [PMID: 31261755]
  9. Antibiotics (Basel). 2022 Jul 06;11(7): [PMID: 35884158]
  10. Antimicrob Agents Chemother. 2020 Feb 21;64(3): [PMID: 31843999]
  11. J Hosp Infect. 2018 Sep;100(1):29-34 [PMID: 29879446]
  12. Microorganisms. 2021 Sep 17;9(9): [PMID: 34576880]
  13. Emerg Infect Dis. 2014 Nov;20(11):1812-20 [PMID: 25341126]
  14. J Hosp Infect. 2018 Sep;100(1):21-28 [PMID: 29763630]
  15. Arch Ital Urol Androl. 2018 Jun 30;90(2):85-96 [PMID: 29974720]
  16. J Clin Med. 2021 May 12;10(10): [PMID: 34066031]
  17. Lancet Infect Dis. 2018 Apr;18(4):358-360 [PMID: 29456042]
  18. Nat Microbiol. 2019 Nov;4(11):1919-1929 [PMID: 31358985]
  19. J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36 [PMID: 28375512]
  20. Genome Res. 2018 Sep;28(9):1395-1404 [PMID: 30049790]
  21. Clin Infect Dis. 2018 Jul 2;67(2):161-170 [PMID: 29340588]
  22. Curr Protoc Bioinformatics. 2020 Jun;70(1):e102 [PMID: 32559359]
  23. J Antimicrob Chemother. 2017 Mar 1;72(3):668-677 [PMID: 27999023]
  24. Lancet Infect Dis. 2022 Mar;22(3):401-412 [PMID: 34767753]
  25. Antibiotics (Basel). 2021 May 07;10(5): [PMID: 34067186]
  26. Ther Adv Infect Dis. 2021 Oct 30;8:20499361211054918 [PMID: 34733509]
  27. Emerg Infect Dis. 2012 Sep;18(9):1503-7 [PMID: 22932472]
  28. Clin Infect Dis. 2017 Apr 01;64(7):839-844 [PMID: 28013258]
  29. Clin Microbiol Infect. 2019 Aug;25(8):943-950 [PMID: 31004767]
  30. J Antimicrob Chemother. 2002 Apr;49(4):651-9 [PMID: 11909839]
  31. Lancet Infect Dis. 2022 Feb;22(2):167-168 [PMID: 35092791]
  32. J Clin Microbiol. 2016 Dec;54(12):2919-2927 [PMID: 27629900]
  33. Lancet Infect Dis. 2022 Mar;22(3):309-310 [PMID: 34767752]
  34. Clin Infect Dis. 2021 Jun 1;72(11):1871-1878 [PMID: 32427286]

Grants

  1. ITMS: 313011T431/European Regional Development Fund
  2. NFP313010V344/European Structural and Investment Funds
  3. SRDA-20-0413/Slovak Research and Development Agency

Word Cloud

Created with Highcharts 10.0.0ST258facilitiesST11hospital3%ST5842CRresistancestrains4%6%clinic7UniversityHospitalantimicrobialcgMLST631foundfirstinternal3healthcareCarbapenem-resistantrepresentsurgentworldwidethreatfocusedselectedBratislavaUHBinvestigatesequencetypesSTsclonalrelatednessSuspectedcarbapenem-nonsusceptibleobtainedhospitalizedpatientsexaminationincludedcarbapenemaseconfirmationquantitativesusceptibilitytestingtotal4126determined2284Six14threeoccurrediefour667%detectedgeriatrictwo48%oneset2492producedNDM-1Furthermoreseven875five100%generatedKPC-2Antimicrobialfollows:ertapenem97meropenemtigecyclineeravacyclinecolistin5%revealedpresumablyepidemiologicalassociationtransmissionparticularlyrelatedinterhospitaldisseminationmedicalessentialpreventcirculationpathogenswithinNext-GenerationSequencingCarbapenem-ResistantStrainsIsolatedPatientsHospitalizedFacilitiescarbapenem-resistantKlebsiellapneumoniae

Similar Articles

Cited By